Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Journal of clinical oncology: official journal of the American Society of Clinical Oncology [J Clin Oncol] NLMUID: 8309333"" wg kryterium: JN


Tytuł :
Virtues of Ruth.
Autorzy :
Muluneh B; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC.; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC.
Pokaż więcej
Źródło :
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2021 Oct 14, pp. JCO2101909. Date of Electronic Publication: 2021 Oct 14.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin Versus Transarterial Chemoembolization for Large Hepatocellular Carcinoma: A Randomized Phase III Trial.
Autorzy :
Li QJ; Department of Hepatobiliary Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
He MK; Department of Hepatobiliary Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
Chen HW; First People's Hospital of Foshan, FoShan, China.
Fang WQ; Kaiping Central Hospital, KaiPing, China.
Zhou YM; Guangzhou No. 12 People's Hospital, Guangzhou, China.
Xu L; Department of Hepatobiliary Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
Wei W; Department of Hepatobiliary Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
Zhang YJ; Department of Hepatobiliary Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
Guo Y; Department of Clinical Research, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
Guo RP; Department of Hepatobiliary Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
Chen MS; Department of Hepatobiliary Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
Shi M; Department of Hepatobiliary Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
Pokaż więcej
Źródło :
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2021 Oct 14, pp. JCO2100608. Date of Electronic Publication: 2021 Oct 14.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
How to Feel Bad.
Autorzy :
Gedye C; Medical Oncology, Calvary Mater Newcastle, Waratah, Australia.; Clinical Trials Unit, Hunter Medical Research Institute, New Lambton Heights, Australia.; University of Newcastle, Callaghan, Australia.
Pokaż więcej
Źródło :
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2021 Oct 10; Vol. 39 (29), pp. 3306-3307. Date of Electronic Publication: 2021 Aug 06.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Beyond the Front Line: Emerging Data for Maintenance Therapy in Pancreatic Cancer.
Autorzy :
Singh H; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Brigham and Women's Hospital, Boston, MA.; Harvard Medical School, Boston, MA.
Perez K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Brigham and Women's Hospital, Boston, MA.; Harvard Medical School, Boston, MA.
Wolpin BM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Brigham and Women's Hospital, Boston, MA.; Harvard Medical School, Boston, MA.
Aguirre AJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Brigham and Women's Hospital, Boston, MA.; Harvard Medical School, Boston, MA.
Pokaż więcej
Źródło :
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2021 Oct 10; Vol. 39 (29), pp. 3199-3206. Date of Electronic Publication: 2021 Aug 24.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Pregnancy After Breast Cancer: A Systematic Review and Meta-Analysis.
Autorzy :
Lambertini M; Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genova, Italy.; Department of Medical Oncology, U.O. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
Blondeaux E; Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genova, Italy.; Breast Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
Bruzzone M; Clinical Epidemiology Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Perachino M; Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genova, Italy.; Department of Medical Oncology, U.O. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
Anderson RA; MRC Centre for Reproductive Health, The Queen's Medical Research Institute, The University of Edinburgh, Edinburgh, United Kingdom.
de Azambuja E; Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium.
Poorvu PD; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston MA.
Kim HJ; Department of Surgical Oncology, Asan Medical Center, Seoul, Korea.
Villarreal-Garza C; Breast Cancer Center, Hospital Zambrano Hellion, Tecnologico de Monterrey, San Pedro Garza Garcia, Nuevo Leon, Mexico.; Department of Breast Tumors, Instituo Nacional de Cancerologia, Mexico City, Mexico.
Pistilli B; Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France.
Vaz-Luis I; Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France.
Saura C; Department of Medical Oncology, Vall d'Hebron University Hospital (HUVH), Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
Ruddy KJ; Division of Medical Oncology, Mayo Clinic, Rochester, MN.
Franzoi MA; Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France.
Sertoli C; Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genova, Italy.
Ceppi M; Clinical Epidemiology Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Azim HA Jr; Breast Cancer Center, Hospital Zambrano Hellion, Tecnologico de Monterrey, San Pedro Garza Garcia, Nuevo Leon, Mexico.
Amant F; Netherlands Cancer Institute and Amsterdam University Medical Centers, Amsterdam, the Netherlands.; Department of Oncology, KU Leuven, Leuven, Belgium.
Demeestere I; Fertility Clinic, CUB-Erasme Hospital, Université Libre de Bruxelles (ULB), Brussels, Belgium.
Del Mastro L; Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genova, Italy.; Breast Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
Partridge AH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston MA.
Pagani O; Geneva University Hospitals, European School of Oncology, Geneva, Switzerland.
Peccatori FA; Fertility and Procreation Unit, Gynecologic Oncology Department, European Institute of Oncology IRCCS, Milan, Italy.
Pokaż więcej
Źródło :
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2021 Oct 10; Vol. 39 (29), pp. 3293-3305. Date of Electronic Publication: 2021 Jul 01.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
ROCKing Chronic Graft-Versus-Host Disease.
Autorzy :
Heine A; Annkristin Heine, MD, and Tobias A. W. Holderried, MD, Department of Oncology, Hematology, Immuneoncology and Rheumatology, University Hospital Bonn, Bonn, Germany and Dominik Wolf, MD, Department of Oncology, Hematology, Immuneoncology and Rheumatology, University Hospital Bonn, Bonn, Germany, Internal Medicine V, Hematology and Oncology, Medical University Innsbruck, Innsbruck, Austria, Laboratory of Tumorimmunology, Tyrolean Cancer Research Institute, Medical University Innsbruck, Innsbruck, Austria.
Holderried TAW; Annkristin Heine, MD, and Tobias A. W. Holderried, MD, Department of Oncology, Hematology, Immuneoncology and Rheumatology, University Hospital Bonn, Bonn, Germany and Dominik Wolf, MD, Department of Oncology, Hematology, Immuneoncology and Rheumatology, University Hospital Bonn, Bonn, Germany, Internal Medicine V, Hematology and Oncology, Medical University Innsbruck, Innsbruck, Austria, Laboratory of Tumorimmunology, Tyrolean Cancer Research Institute, Medical University Innsbruck, Innsbruck, Austria.
Wolf D; Annkristin Heine, MD, and Tobias A. W. Holderried, MD, Department of Oncology, Hematology, Immuneoncology and Rheumatology, University Hospital Bonn, Bonn, Germany and Dominik Wolf, MD, Department of Oncology, Hematology, Immuneoncology and Rheumatology, University Hospital Bonn, Bonn, Germany, Internal Medicine V, Hematology and Oncology, Medical University Innsbruck, Innsbruck, Austria, Laboratory of Tumorimmunology, Tyrolean Cancer Research Institute, Medical University Innsbruck, Innsbruck, Austria.
Pokaż więcej
Źródło :
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2021 Oct 10; Vol. 39 (29), pp. 3308. Date of Electronic Publication: 2021 Aug 04.
Typ publikacji :
Letter
Opinia redakcyjna
Tytuł :
Gonadal Function Recovery in Patients With Advanced Hodgkin Lymphoma Treated With a PET-Adapted Regimen: Prospective Analysis of a Randomized Phase III Trial (AHL2011).
Autorzy :
Demeestere I; Research Laboratory on Human Reproduction and Fertility Clinic, CUB-Erasme, Université Libre de Bruxelles, Brussels, Belgium.
Racape J; Research Center in Epidemiology, Biostatistics and Clinical Research, School of Public Health, and Biomedical Research Department, CUB-Erasme, Université Libre de Bruxelles, Brussels, Belgium.
Dechene J; Research Laboratory on Human Reproduction, Université Libre de Bruxelles, Brussels, Belgium.
Dupuis J; Department of Haematology, Hopital H. Mondor, Creteil, France.
Morschhauser F; Department of Hematology, University of Lille, CHU Lille, EA 7365-GRITA-Groupe de Recherche sur les formes Injectables et les Technologies Associées, Lille, France.
De Wilde V; Department of Haematology, CUB-Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium.
Lazarovici J; Department of Haematology Gustave Roussy, Université Paris-Saclay, Villejuif, France.
Ghesquieres H; Department of Haematology, Hospices Civils de Lyon, Centre Hospitalier Lyon-Sud, et Université Claude Bernard Lyon-1, Pierre Bénite, France.
Touati M; Department of Haematology, CHU Limoges, Limoges, France.
Sibon D; Department of Haematology, Hopital Necker, Paris, France.
Alexis M; Department of Haematology, CH Orleans, Orleans, France.
Gac AC; Department of Haematology, Institut d'hématologie de basse normandie, Caen, France.
Moatti H; Department of Haematology, APHP, Hopital Saint Louis, Paris, France.
Virelizier E; Department of Haematology, Centre L. Bérard, Lyon, France.
Maisonneuve H; Department of Haematology, Hopital departemental de Vendée, La Roche sur Yon, France.
Pranger D; Department of Haematology, Grand Hopital de Charleroi, Charleroi, Belgium.
Houot R; Department of Hematology, University Hospital of Rennes, Rennes, France.
Fornecker LM; Department of Hematology, University Hospital of Strasbourg, Strasbourg, France.
Tempescul A; Department of Hematology, University Hospital of Brest, Brest, France.
André M; Department of Haematology, CHU UCL Namur, Université catholique de Louvain, Yvoir, Belgium.
Casasnovas RO; Department of Haematology, University Hospital F Mitterrand and Inserm UMR1231, Dijon, France.
Pokaż więcej
Źródło :
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2021 Oct 10; Vol. 39 (29), pp. 3251-3260. Date of Electronic Publication: 2021 Jun 22.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Revised Neuroblastoma Risk Classification System: A Report From the Children's Oncology Group.
Autorzy :
Irwin MS; Department of Pediatrics, Hospital for Sick Children, Toronto, ON, Canada.
Naranjo A; Children's Oncology Group Statistics and Data Center, Department of Biostatistics, University of Florida, Gainesville, FL.
Zhang FF; Children's Oncology Group Statistics and Data Center, Monrovia, CA.
Cohn SL; Department of Pediatrics, The University of Chicago, Chicago, IL.
London WB; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA.
Gastier-Foster JM; Institute for Genomic Medicine and Biopathology Center, Nationwide Children's Hospital, Columbus, OH.; Departments of Pathology and Pediatrics, Ohio State University, Columbus, OH.
Ramirez NC; Institute for Genomic Medicine and Biopathology Center, Nationwide Children's Hospital, Columbus, OH.; Departments of Pathology and Pediatrics, Ohio State University, Columbus, OH.
Pfau R; Institute for Genomic Medicine and Biopathology Center, Nationwide Children's Hospital, Columbus, OH.; Departments of Pathology and Pediatrics, Ohio State University, Columbus, OH.
Reshmi S; Institute for Genomic Medicine and Biopathology Center, Nationwide Children's Hospital, Columbus, OH.; Departments of Pathology and Pediatrics, Ohio State University, Columbus, OH.
Wagner E; Institute for Genomic Medicine and Biopathology Center, Nationwide Children's Hospital, Columbus, OH.
Nuchtern J; Division of Pediatric Surgery, Department of Surgery, Texas Children's Hospital, Baylor College of Medicine, Houston, TX.
Asgharzadeh S; Division of Hematology/Oncology, Children's Hospital of Los Angeles, Los Angeles, CA.
Shimada H; Departments of Pathology and Pediatrics, Stanford University, Stanford, CA.
Maris JM; Department of Pediatrics, Children's Hospital of Philadelphia and Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
Bagatell R; Department of Pediatrics, Children's Hospital of Philadelphia and Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
Park JR; Department of Pediatrics, Seattle Children's Hospital, University of Washington, Seattle, WA.
Hogarty MD; Department of Pediatrics, Children's Hospital of Philadelphia and Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
Pokaż więcej
Źródło :
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2021 Oct 10; Vol. 39 (29), pp. 3229-3241. Date of Electronic Publication: 2021 Jul 28.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Physical Activity Patterns and Relationships With Cognitive Function in Patients With Breast Cancer Before, During, and After Chemotherapy in a Prospective, Nationwide Study.
Autorzy :
Salerno EA; Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine in St Louis, St Louis, MO.; Division of Cancer Epidemiology and Genetics, Metabolic Epidemiology Branch, National Cancer Institute, Rockville, MD.
Culakova E; Department of Surgery, University of Rochester Medical Center, Rochester, NY.
Kleckner AS; Department of Surgery, University of Rochester Medical Center, Rochester, NY.; Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY.
Heckler CE; Department of Surgery, University of Rochester Medical Center, Rochester, NY.; Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY.
Lin PJ; Department of Surgery, University of Rochester Medical Center, Rochester, NY.; Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY.
Matthews CE; Division of Cancer Epidemiology and Genetics, Metabolic Epidemiology Branch, National Cancer Institute, Rockville, MD.
Conlin A; Pacific Cancer Research Consortium-National Cancer Institute Community Clinical Oncology Research Program (NCORP), Seattle, WA.
Weiselberg L; North Shore LIJ Health System NCORP, Lake Success, NY.
Mitchell J; Columbus NCORP, Columbus, OH.
Mustian KM; Department of Surgery, University of Rochester Medical Center, Rochester, NY.; Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY.
Janelsins MC; Department of Surgery, University of Rochester Medical Center, Rochester, NY.; Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY.
Pokaż więcej
Źródło :
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2021 Oct 10; Vol. 39 (29), pp. 3283-3292. Date of Electronic Publication: 2021 Aug 18.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Open-Label Phase II Prospective, Randomized, Controlled Study of Romyelocel-L Myeloid Progenitor Cells to Reduce Infection During Induction Chemotherapy for Acute Myeloid Leukemia.
Autorzy :
Desai PM; Weill Cornell Medical College, New York, NY.
Brown J; Stanford University Medical Center, Stanford, CA.
Gill S; University of Pennsylvania, Philadelphia, PA.
Solh MM; Northside Hospital, Atlanta, GA.
Akard LP; Indiana Blood and Marrow Transplantation, Indianapolis, IN.
Hsu JW; University of Florida, Gainesville, FL.
Ustun C; University of Minnesota, St Paul, MN.
Andreadis C; University of California San Francisco, San Francisco, CA.
Frankfurt O; Northwestern University, Chicago, IL.
Foran JM; Mayo Clinic, Jacksonville, FL.
Lister J; Allegheny Health Network, Pittsburgh, PA.
Schiller GJ; David Geffen School of Medicine at UCLA, Los Angeles, CA.
Wieduwilt MJ; Stephenson Cancer Center, University of Oklahoma, Oklahoma City, OK.
Pagel JM; Swedish Cancer Institute, Seattle, WA.
Stiff PJ; Loyola University Stritch School of Medicine, Maywood, IL.
Liu D; New York Medical College, Hawthorne, NY.
Khan I; University of Illinois Cancer Center, Chicago, IL.
Stock W; University of Chicago, Chicago, IL.
Kambhampati S; Kansas City Veterans Affairs Medical Center, Kansas City, MO.
Tallman MS; Memorial Sloan Kettering Cancer Center, New York, NY.
Morris L; Northside Hospital, Atlanta, GA.
Edwards J; Indiana Blood and Marrow Transplantation, Indianapolis, IN.
Pusic I; Washington University, St Louis, MO.
Kantarjian HM; The University of Texas MD Anderson Cancer Center, Houston, TX.
Mamelok R; Cellerant Therapeutics, San Carlos, CA.
Wong A; Cellerant Therapeutics, San Carlos, CA.
Van Syoc R; Cellerant Therapeutics, San Carlos, CA.
Kellerman L; Cellerant Therapeutics, San Carlos, CA.
Panuganti S; Cellerant Therapeutics, San Carlos, CA.
Mandalam R; Cellerant Therapeutics, San Carlos, CA.
Abboud CN; Washington University, St Louis, MO.
Ravandi F; The University of Texas MD Anderson Cancer Center, Houston, TX.
Pokaż więcej
Źródło :
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2021 Oct 10; Vol. 39 (29), pp. 3261-3272. Date of Electronic Publication: 2021 Jun 22.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Randomized Phase II Trial Evaluating Two Sequential Treatments in First Line of Metastatic Pancreatic Cancer: Results of the PANOPTIMOX-PRODIGE 35 Trial.
Autorzy :
Dahan L; Department of Digestive Oncology, La Timone, Aix Marseille Université, Marseille, France.
Williet N; Hepatogastroenterology Department, University Hospital of Saint-Etienne, Saint-Etienne, France.
Le Malicot K; Biostatistics Department, Fédération Francphone de Cancérologie Digestive, EPICAD INSERM LNC-UMR 1231 University of Burgundy and Franche Comté, Dijon, France.
Phelip JM; Hepatogastroenterology Department, University Hospital of Saint-Etienne, Saint-Etienne, France.
Desrame J; Cancerology Institute, Jean-Mermoz Private Hospital, Lyon, France.
Bouché O; Department of Digestive Oncology, CHU Reims, Reims, France.
Petorin C; Hepatogastroenterology Department, Estaing University Hospital, Clermont Ferrand, France.
Malka D; Cancerology Department, Gustave Roussy Institute, Villejuif, France.
Rebischung C; Cancerology Department, Daniel Hollard Institute, Grenoble, France.
Aparicio T; Department of Gastroenterology and Digestive Oncology, Saint Louis Hospital, APHP, Paris, France.
Lecaille C; Cancerology Department, Bordeaux Nord Polyclinic, Bordeaux, France.
Rinaldi Y; Hepatogastroenterology Department, European Hospital of Marseille, Marseille, France.
Turpin A; Department of Medical Oncology, University Lille, CNRS UMR9020, Inserm UMR-S 1277-Canther-Cancer Heterogeneity, Plasticity and Resistance to Therapies, CHU Lille, Lille, France.
Bignon AL; Hepatogastroenterology Department, University Hospital of Caen, Caen, France.
Bachet JB; Sorbonne University, UPMC, IUC, Paris 6, Hepato-Gastroenterology and Digestive Oncology Department, Pitié Salpêtrière Hospital, Paris, France.
Seitz JF; Department of Digestive Oncology, La Timone, Aix Marseille Université, Marseille, France.
Lepage C; Hepatogastroenterology and Cancerology Department, Dijon Bourgogne Hospital, Dijon, France.; Fédération Francophone de Cancérologie Digestive, EPICAD INSERM LNC-UMR 1231 University of Burgundy and Franche Comté, Dijon, France.
François E; Cancerology Department, Antoine Lacassagne Centre, Nice, France.
Pokaż więcej
Corporate Authors :
PRODIGE 35 Investigators/Collaborators
Źródło :
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2021 Oct 10; Vol. 39 (29), pp. 3242-3250. Date of Electronic Publication: 2021 Jul 21.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Gemcitabine Plus Cisplatin Versus Fluorouracil Plus Cisplatin as First-Line Therapy for Recurrent or Metastatic Nasopharyngeal Carcinoma: Final Overall Survival Analysis of GEM20110714 Phase III Study.
Autorzy :
Hong S; Department of Medical Oncology of Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University, Guangzhou, China.
Zhang Y; Department of Medical Oncology of Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University, Guangzhou, China.
Yu G; Department of Medical Oncology, Jiangmen Central Hospital, Jiangmen, China.
Peng P; Department of Medical Oncology, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, China.
Peng J; Department of Medical Oncology, Zhongshan People's Hospital, Zhongshan, China.
Jia J; Department of Medical Oncology, Dongguan People's Hospital, Dongguan, China.
Wu X; Department of Medical Oncology, Peking University Shenzhen Hospital, Shenzhen, China.
Huang Y; Department of Medical Oncology of Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University, Guangzhou, China.
Yang Y; Department of Medical Oncology of Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University, Guangzhou, China.
Lin Q; Department of Oncology, Shunde Hospital Guangzhou University of Chinese Medicine, Foshan, China.
Xi X; Department of Radiotherapy, Cancer Hospital of Hunan Province, Changsha, China.
Xu M; Department of Oncology, The First Affiliated Hospital of Gangnan Medical College, Gangnan, China.
Chen D; Department of Radiotherapy, The Affiliated Cancer Hospital of Guangzhou Medical University, Guangzhou, China.
Lu X; Department of Radiotherapy, Zhongshan People's Hospital, Zhongshan, China.
Wang R; Department of Radiotherapy, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Cao X; Department of Oncology, Panyu Central Hospital, Guangzhou, China.
Chen X; Department of Radiotherapy, Cancer Hospital of Zhejiang Province, Hangzhou, China.
Lin Z; Department of Medical Oncology, The Affiliated Cancer Hospital of Shantou University, Shantou, China.
Xiong J; Department of Oncology, The First Affiliated Hospital of Nanchang University, Nanchang, China.
Lin Q; Department of Radiotherapy, The First Affiliated Hospital of Xiamen University, Xiamen, China.
Xie C; Department of Oncology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Li Z; Department of Oncology, Sun Yat-sen Memorial Hospital, Guangzhou, China.
Pan J; Department of Radiotherapy, Fujian Provincial Cancer Hospital, Fuzhou, China.
Li J; Department of Radiotherapy, Jiangxi Provincial Cancer Hospital, Nanchang, China.
Wu S; Department of Radiotherapy, Cancer Hospital of Hangzhou City, Hangzhou, China.
Lian Y; Department of Medical Oncology, The First People's Hospital of Zhaoqing City, Zhaoqing, China.
Yang Q; Department of Chemotherapy, People's Hospital of Meizhou, Meizhou, China.
Zhao C; Department of Nasopharyngeal Carcinoma of Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University, Guangzhou, China.
Fang W; Department of Medical Oncology of Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University, Guangzhou, China.
Zhang L; Department of Medical Oncology of Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University, Guangzhou, China.
Pokaż więcej
Źródło :
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2021 Oct 10; Vol. 39 (29), pp. 3273-3282. Date of Electronic Publication: 2021 Aug 11.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Reply to A. Heine et al.
Autorzy :
Lazaryan A; Aleksandr Lazaryan, MD, MPH, PhD, Moffitt Cancer Center, Tampa, FL and Stephanie J. Lee, MD, MPH, Fred Hutchinson Cancer Research Center, Seattle, WA.
Lee SJ; Aleksandr Lazaryan, MD, MPH, PhD, Moffitt Cancer Center, Tampa, FL and Stephanie J. Lee, MD, MPH, Fred Hutchinson Cancer Research Center, Seattle, WA.
Pokaż więcej
Źródło :
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2021 Oct 10; Vol. 39 (29), pp. 3308-3309. Date of Electronic Publication: 2021 Aug 04.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
FOXR2 Stabilizes MYCN Protein and Identifies Non- MYCN -Amplified Neuroblastoma Patients With Unfavorable Outcome.
Autorzy :
Schmitt-Hoffner F; Hopp-Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.
van Rijn S; Hopp-Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.
Toprak UH; Hopp-Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Division of Neuroblastoma Genomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Mauermann M; Hopp-Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.
Rosemann F; Hopp-Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.
Heit-Mondrzyk A; Hopp-Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.
Hübner JM; Hopp-Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.
Camgöz A; Hopp-Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Dresden, Germany.
Hartlieb S; Hopp-Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Division of Neuroblastoma Genomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Pfister SM; Hopp-Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.; Department of Pediatric Hematology and Oncology, Heidelberg University Hospital, Heidelberg, Germany.
Henrich KO; Hopp-Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Division of Neuroblastoma Genomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Westermann F; Hopp-Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Division of Neuroblastoma Genomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Kool M; Hopp-Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
Pokaż więcej
Źródło :
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2021 Oct 10; Vol. 39 (29), pp. 3217-3228. Date of Electronic Publication: 2021 Jun 10.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Utility of a Cancer Predisposition Screening Tool for Predicting Subsequent Malignant Neoplasms in Childhood Cancer Survivors.
Autorzy :
Cullinan N; Division of Hematology/Oncology, Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.; Department of Haematology/Oncology, Children's Health Ireland (CHI) at Crumlin, Dublin, Ireland.
Schiller I; Centre for Outcomes Research (CORE), Research Institute of the McGill University Health Centre, McGill University, Montreal, Quebec, Canada.
Di Giuseppe G; Pediatric Oncology Group of Ontario, Toronto, Ontario, Canada.; Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
Mamun M; Division of Hematology/Oncology, Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
Reichman L; Research Institute of the McGill University Health Centre, Child Health and Human Development, McGill University, Montreal, Quebec, Canada.
Cacciotti C; Division of Hematology/Oncology, McMaster Children's Hospital, Hamilton Health Sciences, Hamilton, Ontario, Canada.; Division of Hematology/Oncology, London Health Sciences Centre, London, Ontario, Canada.
Wheaton L; Division of Hematology/Oncology, Kingston Health Sciences Centre, Kingston, Ontario, Canada.
Caswell K; Division of Hematology/Oncology, Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
Di Monte B; Pediatric Oncology Group of Ontario, Toronto, Ontario, Canada.
Gibson P; Division of Hematology/Oncology, McMaster Children's Hospital, Hamilton Health Sciences, Hamilton, Ontario, Canada.
Johnston DL; Division of Hematology/Oncology, Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada.
Fleming A; Division of Hematology/Oncology, McMaster Children's Hospital, Hamilton Health Sciences, Hamilton, Ontario, Canada.
Pole JD; Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.; Centre for Health Services Research, University of Queensland, Brisbane, Australia.
Malkin D; Division of Hematology/Oncology, Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
Foulkes WD; Department of Human Genetics, Cancer Research Program, McGill University Health Centre and Lady Davis Institute, Jewish General Hospital, McGill University, Montreal, Quebec, Canada.
Dendukuri N; Centre for Outcomes Research (CORE), Research Institute of the McGill University Health Centre, McGill University, Montreal, Quebec, Canada.
Goudie C; Research Institute of the McGill University Health Centre, Child Health and Human Development, McGill University, Montreal, Quebec, Canada.; Division of Hematology/Oncology, Department of Pediatrics, Montreal Children's Hospital, McGill University Health Centre, Montreal, Quebec, Canada.
Nathan PC; Division of Hematology/Oncology, Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
Pokaż więcej
Źródło :
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2021 Oct 10; Vol. 39 (29), pp. 3207-3216. Date of Electronic Publication: 2021 Aug 12.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Identifying Childhood Cancer Survivors at Increased Genetic Risk for Second Malignant Neoplasms: Use of a Novel Screening Tool.
Autorzy :
Mostafavi RM; Department of Oncology, St Jude Children's Research Hospital, Memphis, TN.
Nichols KE; Department of Oncology, St Jude Children's Research Hospital, Memphis, TN.
Pokaż więcej
Źródło :
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2021 Oct 10; Vol. 39 (29), pp. 3195-3198. Date of Electronic Publication: 2021 Sep 02.
Typ publikacji :
Editorial
Opinia redakcyjna
Tytuł :
Reply to K. Takada et al.
Autorzy :
Sharafeldin N; Noha Sharafeldin, MD, MSc, PhD, University of Alabama at Birmingham, School of Medicine, Birmingham, AL; Benjamin Bates, MD, Rutgers University, New Brunswick, NJ; Qianqian Song, PhD, Wake Forest School of Medicine, Winston-Salem, NC; Vithal Madhira, MS, Palila Software LLC, Reno, NV; Yu Raymond Shao, MD, PhD, Duke University Medical Center, Durham, NC; Feifan Liu, PhD, University of Massachusetts Medical School, Boston, MA; Timothy Bergquist, PhD, Sage Bionetworks, Seattle, WA; Jing Su, PhD, Department of Biostatistics, Indiana University School of Medicine, Indianapolis, IN; and Umit Topaloglu, PhD, Wake Forest School of Medicine, Winston-Salem, NC.
Bates B; Noha Sharafeldin, MD, MSc, PhD, University of Alabama at Birmingham, School of Medicine, Birmingham, AL; Benjamin Bates, MD, Rutgers University, New Brunswick, NJ; Qianqian Song, PhD, Wake Forest School of Medicine, Winston-Salem, NC; Vithal Madhira, MS, Palila Software LLC, Reno, NV; Yu Raymond Shao, MD, PhD, Duke University Medical Center, Durham, NC; Feifan Liu, PhD, University of Massachusetts Medical School, Boston, MA; Timothy Bergquist, PhD, Sage Bionetworks, Seattle, WA; Jing Su, PhD, Department of Biostatistics, Indiana University School of Medicine, Indianapolis, IN; and Umit Topaloglu, PhD, Wake Forest School of Medicine, Winston-Salem, NC.
Song Q; Noha Sharafeldin, MD, MSc, PhD, University of Alabama at Birmingham, School of Medicine, Birmingham, AL; Benjamin Bates, MD, Rutgers University, New Brunswick, NJ; Qianqian Song, PhD, Wake Forest School of Medicine, Winston-Salem, NC; Vithal Madhira, MS, Palila Software LLC, Reno, NV; Yu Raymond Shao, MD, PhD, Duke University Medical Center, Durham, NC; Feifan Liu, PhD, University of Massachusetts Medical School, Boston, MA; Timothy Bergquist, PhD, Sage Bionetworks, Seattle, WA; Jing Su, PhD, Department of Biostatistics, Indiana University School of Medicine, Indianapolis, IN; and Umit Topaloglu, PhD, Wake Forest School of Medicine, Winston-Salem, NC.
Madhira V; Noha Sharafeldin, MD, MSc, PhD, University of Alabama at Birmingham, School of Medicine, Birmingham, AL; Benjamin Bates, MD, Rutgers University, New Brunswick, NJ; Qianqian Song, PhD, Wake Forest School of Medicine, Winston-Salem, NC; Vithal Madhira, MS, Palila Software LLC, Reno, NV; Yu Raymond Shao, MD, PhD, Duke University Medical Center, Durham, NC; Feifan Liu, PhD, University of Massachusetts Medical School, Boston, MA; Timothy Bergquist, PhD, Sage Bionetworks, Seattle, WA; Jing Su, PhD, Department of Biostatistics, Indiana University School of Medicine, Indianapolis, IN; and Umit Topaloglu, PhD, Wake Forest School of Medicine, Winston-Salem, NC.
Shao YR; Noha Sharafeldin, MD, MSc, PhD, University of Alabama at Birmingham, School of Medicine, Birmingham, AL; Benjamin Bates, MD, Rutgers University, New Brunswick, NJ; Qianqian Song, PhD, Wake Forest School of Medicine, Winston-Salem, NC; Vithal Madhira, MS, Palila Software LLC, Reno, NV; Yu Raymond Shao, MD, PhD, Duke University Medical Center, Durham, NC; Feifan Liu, PhD, University of Massachusetts Medical School, Boston, MA; Timothy Bergquist, PhD, Sage Bionetworks, Seattle, WA; Jing Su, PhD, Department of Biostatistics, Indiana University School of Medicine, Indianapolis, IN; and Umit Topaloglu, PhD, Wake Forest School of Medicine, Winston-Salem, NC.
Liu F; Noha Sharafeldin, MD, MSc, PhD, University of Alabama at Birmingham, School of Medicine, Birmingham, AL; Benjamin Bates, MD, Rutgers University, New Brunswick, NJ; Qianqian Song, PhD, Wake Forest School of Medicine, Winston-Salem, NC; Vithal Madhira, MS, Palila Software LLC, Reno, NV; Yu Raymond Shao, MD, PhD, Duke University Medical Center, Durham, NC; Feifan Liu, PhD, University of Massachusetts Medical School, Boston, MA; Timothy Bergquist, PhD, Sage Bionetworks, Seattle, WA; Jing Su, PhD, Department of Biostatistics, Indiana University School of Medicine, Indianapolis, IN; and Umit Topaloglu, PhD, Wake Forest School of Medicine, Winston-Salem, NC.
Bergquist T; Noha Sharafeldin, MD, MSc, PhD, University of Alabama at Birmingham, School of Medicine, Birmingham, AL; Benjamin Bates, MD, Rutgers University, New Brunswick, NJ; Qianqian Song, PhD, Wake Forest School of Medicine, Winston-Salem, NC; Vithal Madhira, MS, Palila Software LLC, Reno, NV; Yu Raymond Shao, MD, PhD, Duke University Medical Center, Durham, NC; Feifan Liu, PhD, University of Massachusetts Medical School, Boston, MA; Timothy Bergquist, PhD, Sage Bionetworks, Seattle, WA; Jing Su, PhD, Department of Biostatistics, Indiana University School of Medicine, Indianapolis, IN; and Umit Topaloglu, PhD, Wake Forest School of Medicine, Winston-Salem, NC.
Su J; Noha Sharafeldin, MD, MSc, PhD, University of Alabama at Birmingham, School of Medicine, Birmingham, AL; Benjamin Bates, MD, Rutgers University, New Brunswick, NJ; Qianqian Song, PhD, Wake Forest School of Medicine, Winston-Salem, NC; Vithal Madhira, MS, Palila Software LLC, Reno, NV; Yu Raymond Shao, MD, PhD, Duke University Medical Center, Durham, NC; Feifan Liu, PhD, University of Massachusetts Medical School, Boston, MA; Timothy Bergquist, PhD, Sage Bionetworks, Seattle, WA; Jing Su, PhD, Department of Biostatistics, Indiana University School of Medicine, Indianapolis, IN; and Umit Topaloglu, PhD, Wake Forest School of Medicine, Winston-Salem, NC.
Topaloglu U; Noha Sharafeldin, MD, MSc, PhD, University of Alabama at Birmingham, School of Medicine, Birmingham, AL; Benjamin Bates, MD, Rutgers University, New Brunswick, NJ; Qianqian Song, PhD, Wake Forest School of Medicine, Winston-Salem, NC; Vithal Madhira, MS, Palila Software LLC, Reno, NV; Yu Raymond Shao, MD, PhD, Duke University Medical Center, Durham, NC; Feifan Liu, PhD, University of Massachusetts Medical School, Boston, MA; Timothy Bergquist, PhD, Sage Bionetworks, Seattle, WA; Jing Su, PhD, Department of Biostatistics, Indiana University School of Medicine, Indianapolis, IN; and Umit Topaloglu, PhD, Wake Forest School of Medicine, Winston-Salem, NC.
Pokaż więcej
Źródło :
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2021 Oct 08, pp. JCO2102150. Date of Electronic Publication: 2021 Oct 08.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Value of Neoadjuvant Radiation Therapy in the Management of Pancreatic Adenocarcinoma.
Autorzy :
Hall WA; Medical College of Wisconsin, Department of Radiation Oncology and the LaBahn Pancreatic Cancer Program, Milwaukee, WI.; Medical College of Wisconsin, Department of Surgery and the LaBahn Pancreatic Cancer Program, Milwaukee, WI.
Dawson LA; Radiation Medicine Program, Princess Margaret Cancer Centre; Department of Radiation Oncology, University of Toronto, Toronto, Canada.
Hong TS; Massachusetts General Hospital, Department of Radiation Oncology, Boston, MA.
Palta M; Duke University, Department of Radiation Oncology, Durham, NC.
Herman JM; Northwell Health, Department of Radiation Oncology, New Hyde Park, NY.
Evans DB; Medical College of Wisconsin, Department of Surgery and the LaBahn Pancreatic Cancer Program, Milwaukee, WI.
Tsai S; Medical College of Wisconsin, Department of Surgery and the LaBahn Pancreatic Cancer Program, Milwaukee, WI.
Ferrone CR; Massachusetts General Hospital, Department of Surgery, Boston, MA.
B Fleming J; Moffitt Cancer Center, Department of Surgery, Tampa, FL.
Chang DT; Stanford Health Care, Department of Radiation Oncology, Stanford, CA.
Crane C; Memorial Sloan-Kettering Cancer Center, Department of Radiation Oncology, New York, NY.
Koong AC; MD Anderson Cancer Center, Department of Radiation Oncology, Houston, TX.
Oar A; Gold Coast University Hospital, Gold Coast, Queensland, Australia.
Parikh P; Henry Ford Health System, Department of Radiation Oncology, Detroit, MI.
Erickson B; Medical College of Wisconsin, Department of Radiation Oncology and the LaBahn Pancreatic Cancer Program, Milwaukee, WI.; Medical College of Wisconsin, Department of Surgery and the LaBahn Pancreatic Cancer Program, Milwaukee, WI.
Hoffe S; Moffitt Cancer Center, Department of Surgery, Tampa, FL.
Goodman KA; Mount Sinai Hospital, Department of Radiation Oncology, New York, NY.
Pokaż więcej
Źródło :
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2021 Oct 08, pp. JCO2101220. Date of Electronic Publication: 2021 Oct 08.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Synovial Sarcoma in Children, Adolescents, and Young Adults: A Report From the Children's Oncology Group ARST0332 Study.
Autorzy :
Venkatramani R; Division of Hematology/Oncology, Department of Pediatrics, Texas Children's Cancer Center, Texas Children's Hospital, Baylor College of Medicine, Houston, TX.
Xue W; Department of Biostatistics, College of Public Health and Health Professions College of Medicine, University of Florida, Gainesville, FL.
Randall RL; UC Davis Department of Orthopedic Surgery, Sacramento, CA.
Wolden S; Memorial Sloan Kettering Cancer Center, New York, NY.
Anderson J; Merck and Co, North Wales, PA.
Lopez-Terrada D; Department of Pathology, Texas Children's Hospital, Baylor College of Medicine, Houston, TX.
Black J; Children's Hospital Colorado, Denver, CO.
Kao SC; Division of Pediatric Radiology, Department of Radiology, Carver College of Medicine and University of Iowa Stead Family Children's Hospital, University of Iowa, Iowa City, IA.
Shulkin B; Department of Diagnostic Imaging, St. Jude Children's Research Hospital, Memphis, TN.; Department of Radiology, University of TN Health Science Center, Memphis, TN.
Ostrenga A; University of Mississippi Medical Center, Jackson, MS.
Pappo A; Department of Oncology, St Jude Children's Research Hospital, Memphis, TN.
Spunt SL; Division of Hematology/Oncology, Department of Pediatrics, Stanford University School of Medicine, Palo Alto, CA.
Pokaż więcej
Źródło :
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2021 Oct 08, pp. JCO2101628. Date of Electronic Publication: 2021 Oct 08.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
A Validated Risk Prediction Model for Breast Cancer in US Black Women.
Autorzy :
Palmer JR; Slone Epidemiology Center at Boston University, Boston, MA.; Boston University School of Medicine, Boston, MA.
Zirpoli G; Slone Epidemiology Center at Boston University, Boston, MA.
Bertrand KA; Slone Epidemiology Center at Boston University, Boston, MA.; Boston University School of Medicine, Boston, MA.
Battaglia T; Boston University School of Medicine, Boston, MA.
Bernstein L; City of Hope Comprehensive Cancer Center, Duarte, CA.
Ambrosone CB; Roswell Park Comprehensive Cancer Center, Buffalo, NY.
Bandera EV; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ.
Troester MA; University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC.
Rosenberg L; Slone Epidemiology Center at Boston University, Boston, MA.
Pfeiffer RM; National Cancer Institute, Division of Cancer Epidemiology and Genetics, Bethesda, MD.
Trinquart L; Boston University School of Public Health, Boston, MA.
Pokaż więcej
Źródło :
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2021 Oct 08, pp. JCO2101236. Date of Electronic Publication: 2021 Oct 08.
Typ publikacji :
Journal Article
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies